Cite
Serum sTREM-1 in adult-onset Still's disease: a novel biomarker of disease activity and a potential predictor of the chronic course.
MLA
Wang, Zhihong, et al. “Serum STREM-1 in Adult-Onset Still’s Disease: A Novel Biomarker of Disease Activity and a Potential Predictor of the Chronic Course.” Rheumatology (Oxford, England), vol. 59, no. 11, Nov. 2020, pp. 3293–302. EBSCOhost, https://doi.org/10.1093/rheumatology/keaa135.
APA
Wang, Z., Chi, H., Sun, Y., Teng, J., Feng, T., Liu, H., Cheng, X., Ye, J., Shi, H., Hu, Q., Jia, J., Liu, T., Wan, L., Zhou, Z., Qiao, X., Yang, C., & Su, Y. (2020). Serum sTREM-1 in adult-onset Still’s disease: a novel biomarker of disease activity and a potential predictor of the chronic course. Rheumatology (Oxford, England), 59(11), 3293–3302. https://doi.org/10.1093/rheumatology/keaa135
Chicago
Wang, Zhihong, Huihui Chi, Yue Sun, Jialin Teng, Tienan Feng, Honglei Liu, Xiaobing Cheng, et al. 2020. “Serum STREM-1 in Adult-Onset Still’s Disease: A Novel Biomarker of Disease Activity and a Potential Predictor of the Chronic Course.” Rheumatology (Oxford, England) 59 (11): 3293–3302. doi:10.1093/rheumatology/keaa135.